Bruker backs FY23 EPS view $2.55-$2.60, consensus $2.58

Raises FY23 revenue view to $2.85B-$2.9B from $2.83B-$2.88B, consensus $2.86B. The company said, “For FY 2023, Bruker is increasing its revenue guidance to a range of $2.85-$2.90 billion, up from prior outlook of $2.83-$2.88 billion. Bruker continues to expect FY 2023 non-GAAP EPS of $2.55-$2.60, or 9.0%-11.0% year-over-year non-GAAP EPS growth, with no change from prior guidance.”